Product Categories
Molecular biology - BluePoint - Blue Point MycoID - BluePoint MtbDRBluePoint MtbDR
Overview
BluePoint MtbDR starts with DNA extraction, and the target DNA is amplified by nucleic acid and reverse dot-blot hybridization (Reverse Dot-blot Hybridization) to detect whether tuberculosis bacteria are resistant to Rimappin and Isoniazid.
Features
When tuberculosis bacteria are resistant to both drugs Rifampin (RIF) and Isoniazid (INH), they are called multidrug-resistant tuberculosis (MDR-TB); BluePoint MtbDR starts with DNA extraction, and the target DNA undergoes nucleic acid amplification and reverse dot blot The reaction (Reverse Dot-blot Hybridization) was completed within 6 hours to test whether tuberculosis bacteria were resistant to Rifapin and Isoniazid.
Please contact: service@coning-biotech.com
Please contact: service@coning-biotech.com
Certification
Research use only